- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 235/02 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
Patent holdings for IPC class C07D 235/02
Total number of patents in this class: 406
10-year publication summary
|
16
|
30
|
35
|
33
|
33
|
23
|
12
|
24
|
16
|
21
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Gruenenthal GmbH | 108 |
15 |
| Glaxo Group Limited | 4145 |
10 |
| AstraZeneca AB | 2857 |
10 |
| LG Chem, Ltd. | 17706 |
9 |
| The Regents of the University of California | 20303 |
9 |
| Boehringer Ingelheim International GmbH | 4636 |
9 |
| Vitae Pharmaceuticals, Inc. | 94 |
9 |
| Allergan, Inc. | 2313 |
7 |
| Medshine Discovery Inc. | 595 |
7 |
| Reata Pharmaceuticals, Inc. | 118 |
7 |
| The University of Queensland | 665 |
7 |
| BASF SE | 21098 |
6 |
| Grünenthal GmbH | 557 |
6 |
| Ligand Pharmaceuticals Incorporated | 169 |
6 |
| The Provost, Fellows, Foundation Scholars, and The Other Members of Board, of The College of The Holy and Undivided Trinity of Queen Elizabeth, Near Dublin | 168 |
6 |
| Merck Sharp & Dohme Corp. | 2189 |
5 |
| Memorial Sloan-Kettering Cancer Center | 1992 |
5 |
| Janssen Pharmaceutica N.V. | 3358 |
4 |
| President and Fellows of Harvard College | 6043 |
4 |
| BioLegend, Inc. | 65 |
4 |
| Other owners | 261 |